Aeolus Pharmaceuticals Receives $1,000,000 New Funding Round

  • Feed Type
  • Date
    8/19/2010
  • Company Name
    Aeolus Pharmaceuticals
  • Mailing Address
    26361 Crown Valley Parkway Mission Viejo, CA 92691
  • Company Description
    Aeolous Pharmaceutical is a biopharmaceutical company that is developing a new class of catalytic antioxidant compunds, referred to as manganoporphyrins, for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology. Over the past decade, Aeolus has synthesizec, developed, and analyzed approximately 200 proprietary catalytic antioxidant compounds, all of which have the same core chemical structure.
  • Website
    http://www.incara.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.